<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="015543-2018"
            EDITION="2018009">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-014582-001</RECEPTION_ID>
      <DELETION_DATE>20180421</DELETION_DATE>
      <FORM_LG_LIST>FR </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>9</NO_OJ>
         <DATE_PUB>20180113</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 009-015543</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:015543-2018:TEXT:FR:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>FR</LG_ORIG>
         <ISO_COUNTRY VALUE="FR"/>
         <IA_URL_GENERAL>http://www.ch-lemans.fr/</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="FRG04">Sarthe</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="FRG04">Sarthe</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="UKI">LONDON</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR101">Paris</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR10">Ile-de-France</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR102">Seine-et-Marne</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRK26">Rhône</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRJ27">Tarn</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRK2">Rhône-Alpes</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRD11">Calvados</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR105">Hauts-de-Seine</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRB04">Indre-et-Loire</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR107">Val-de-Marne</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRK14">Puy-de-Dôme</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FR103">Yvelines</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRE11">Nord</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="FRL03">Alpes-Maritimes</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">162050.04</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 141-289541</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180111</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Фpaнция</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Francie</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Frankrig</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Frankreich</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γαλλία</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Prantsusmaa</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Ranska</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Fhrainc, an</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Francuska</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Franciaország</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Prancūzija</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Franza</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Frankrijk</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Francja</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>França</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Franţa</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Francúzsko</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Frankrike</TI_CY>
            <TI_TOWN>Le Mans</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="FR">CH Le Mans</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="FR">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>CH Le Mans</OFFICIALNAME>
               <ADDRESS>194 avenue Rubillard</ADDRESS>
               <TOWN>Le Mans Cedex 09</TOWN>
               <POSTAL_CODE>72037</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <E_MAIL>celluledesmarches@ch-lemans.fr</E_MAIL>
               <n2016:NUTS CODE="FRG04"/>
               <URL_GENERAL>http://www.ch-lemans.fr/</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE_OTHER>Établissement Public de Santé</CA_TYPE_OTHER>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Fourniture de spécialités pharmaceutiques des classes ATC: C-D-G-H-M-N-P-S</P>
            </TITLE>
            <REFERENCE_NUMBER>PH2018-504</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Fourniture de spécialités pharmaceutiques des classes ATC: C-D-G-H-M-N-P-S.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">162050.04</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Adenosine phosphate</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Adenosine phosphate.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Côut d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Altizide + spironolactone</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Altizide + spironolactone.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>Amiloride + hydrochlorothiazide</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Amiloride + hydrochlorothiazide.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêt thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>Antihemorroidaire/anesthesique local</P>
               </TITLE>
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Antihemorroidaire/anesthesique local.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <TITLE>
                  <P>Bisoprolol + hydrochlorothiazide</P>
               </TITLE>
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Bisoprolol + hydrochlorothiazide.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="6">
               <TITLE>
                  <P>Celiprolol</P>
               </TITLE>
               <LOT_NO>6</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Celiprolol.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="7">
               <TITLE>
                  <P>Flavonoides extraits de rutacees</P>
               </TITLE>
               <LOT_NO>7</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Flavonoides extraits de rutacees.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="8">
               <TITLE>
                  <P>Acide fusidique 2 % Creme</P>
               </TITLE>
               <LOT_NO>8</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Acide fusidique 2 % Creme</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="9">
               <TITLE>
                  <P>Acide fusidique 2 % Pommade</P>
               </TITLE>
               <LOT_NO>9</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Acide fusidique 2 % Pommade.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="10">
               <TITLE>
                  <P>Ciclopirox</P>
               </TITLE>
               <LOT_NO>10</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Ciclopirox.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="11">
               <TITLE>
                  <P>Dermocorticoide D'Activite moderee (ii)</P>
               </TITLE>
               <LOT_NO>11</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Dermocorticoide D'Activite moderee (ii).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="12">
               <TITLE>
                  <P>Dermocorticoide D'Activite moderee (ii)</P>
               </TITLE>
               <LOT_NO>12</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Dermocorticoide D'Activite moderee (ii).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="13">
               <TITLE>
                  <P>Dermocorticoide D'Activite moderee (ii)</P>
               </TITLE>
               <LOT_NO>13</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Dermocorticoide D'Activite moderee (ii).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="14">
               <TITLE>
                  <P>Emollient pour dermatites atopiques</P>
               </TITLE>
               <LOT_NO>14</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Emollient pour dermatites atopiques.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="15">
               <TITLE>
                  <P>Eosine aqueuse 2 %</P>
               </TITLE>
               <LOT_NO>15</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Eosine aqueuse 2 %.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="16">
               <TITLE>
                  <P>Liniment oleocalcaire</P>
               </TITLE>
               <LOT_NO>16</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Liniment oleocalcaire.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="17">
               <TITLE>
                  <P>Traitement contre les traumatismes benins (contusions)</P>
               </TITLE>
               <LOT_NO>17</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Traitement contre les traumatismes benins (contusions).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="18">
               <TITLE>
                  <P>Traitement local cuivre-zinc</P>
               </TITLE>
               <LOT_NO>18</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Traitement local cuivre-zinc.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="19">
               <TITLE>
                  <P>Traitement local des dermites irritatives a base d'au moins 20 % d'oxyde de zinc</P>
               </TITLE>
               <LOT_NO>19</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Traitement local des dermites irritatives a base d'au moins 20 % d'oxyde de zinc.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="20">
               <TITLE>
                  <P>Trolamine</P>
               </TITLE>
               <LOT_NO>20</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Trolamine.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="21">
               <TITLE>
                  <P>Vaseline salicylee 10 %</P>
               </TITLE>
               <LOT_NO>21</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Vaseline salicylee 10 %.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="22">
               <TITLE>
                  <P>Artemether + lumefantrine</P>
               </TITLE>
               <LOT_NO>22</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Artemether + lumefantrine.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Inrérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="23">
               <TITLE>
                  <P>Benzyle benzoate</P>
               </TITLE>
               <LOT_NO>23</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Benzyle benzoate.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="24">
               <TITLE>
                  <P>Desinfectant antiparasitaire p/usage externe (vetements, literie)</P>
               </TITLE>
               <LOT_NO>24</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Desinfectant antiparasitaire p/usage externe (vetements, literie).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="25">
               <TITLE>
                  <P>Diethyl carbamazine</P>
               </TITLE>
               <LOT_NO>25</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Diethyl carbamazine.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="26">
               <TITLE>
                  <P>Permethrine pour usage externe</P>
               </TITLE>
               <LOT_NO>26</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Permethrine pour usage externe.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="27">
               <TITLE>
                  <P>Pramocaine</P>
               </TITLE>
               <LOT_NO>27</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Pramocaine.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="28">
               <TITLE>
                  <P>Traitement des pediculoses du cuir chevelu (poux de tête) malathion</P>
               </TITLE>
               <LOT_NO>28</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Traitement des pediculoses du cuir chevelu (poux de tête) malathion.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="29">
               <TITLE>
                  <P>Traitement des pediculoses du cuir chevelu (poux de tête) pyrethines</P>
               </TITLE>
               <LOT_NO>29</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Traitement des pediculoses du cuir chevelu (poux de tête) pyrethines.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="30">
               <TITLE>
                  <P>Carbomere</P>
               </TITLE>
               <LOT_NO>30</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Carbomere.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="31">
               <TITLE>
                  <P>Ether</P>
               </TITLE>
               <LOT_NO>31</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Ether.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="32">
               <TITLE>
                  <P>Vert de lissamine</P>
               </TITLE>
               <LOT_NO>32</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Vert de lissamine.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="33">
               <TITLE>
                  <P>Alpha-bloquant dans L'Adenome PROSTATIQUE</P>
               </TITLE>
               <LOT_NO>33</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Alpha-bloquant dans L'Adenome PROSTATIQUE.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="34">
               <TITLE>
                  <P>Salbutamol</P>
               </TITLE>
               <LOT_NO>34</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Salbutamol.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="35">
               <TITLE>
                  <P>Amitriplyne forme orale seche</P>
               </TITLE>
               <LOT_NO>35</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Amitriplyne forme orale seche.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="36">
               <TITLE>
                  <P>Amitriptyline forme injectable</P>
               </TITLE>
               <LOT_NO>36</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Amitriptyline forme injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="37">
               <TITLE>
                  <P>Amitriptyline forme orale liquide</P>
               </TITLE>
               <LOT_NO>37</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Amitriptyline forme orale liquide.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="38">
               <TITLE>
                  <P>Atomoxetine forme orale</P>
               </TITLE>
               <LOT_NO>38</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Atomoxetine forme orale.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="39">
               <TITLE>
                  <P>Cafeine citrate</P>
               </TITLE>
               <LOT_NO>39</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Cafeine citrate.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="40">
               <TITLE>
                  <P>Clotiazepam</P>
               </TITLE>
               <LOT_NO>40</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Clotiazepam.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="41">
               <TITLE>
                  <P>Dexamphetamine forme orale</P>
               </TITLE>
               <LOT_NO>41</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Dexamphetamine forme orale.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="42">
               <TITLE>
                  <P>Doxepine</P>
               </TITLE>
               <LOT_NO>42</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Doxepine.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="43">
               <TITLE>
                  <P>Fentanyl forme orale a liberation immediae</P>
               </TITLE>
               <LOT_NO>43</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Fentanyl forme orale a liberation immediae.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="44">
               <TITLE>
                  <P>Hydromorphone forme orale a liberation prolongee</P>
               </TITLE>
               <LOT_NO>44</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Hydromorphone forme orale a liberation prolongee.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="45">
               <TITLE>
                  <P>Hydroxyzine injectable</P>
               </TITLE>
               <LOT_NO>45</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Hydroxyzine injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="46">
               <TITLE>
                  <P>Levodopa + benserazide forme orale</P>
               </TITLE>
               <LOT_NO>46</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Levodopa + benserazide forme orale.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="47">
               <TITLE>
                  <P>Lidocaine noradrenaline</P>
               </TITLE>
               <LOT_NO>47</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Lidocaine noradrenaline.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="48">
               <TITLE>
                  <P>Loprazolam</P>
               </TITLE>
               <LOT_NO>48</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Loprazolam.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="49">
               <TITLE>
                  <P>Morphine chlorhydrate</P>
               </TITLE>
               <LOT_NO>49</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Morphine chlorhydrate.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="50">
               <TITLE>
                  <P>Morphine sulfate forme lp</P>
               </TITLE>
               <LOT_NO>50</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Morphine sulfate forme lp.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="51">
               <TITLE>
                  <P>Morphine sulfate liberation immediate</P>
               </TITLE>
               <LOT_NO>51</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Morphine sulfate liberation immediate.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="52">
               <TITLE>
                  <P>Nordazepam</P>
               </TITLE>
               <LOT_NO>52</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Nordazepam.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="53">
               <TITLE>
                  <P>Oxycodone forme injectable</P>
               </TITLE>
               <LOT_NO>53</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Oxycodone forme injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="54">
               <TITLE>
                  <P>Oxycodone forme orale liquide</P>
               </TITLE>
               <LOT_NO>54</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Oxycodone forme orale liquide.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="55">
               <TITLE>
                  <P>Oxycodone forme orale seche a liberation immediate</P>
               </TITLE>
               <LOT_NO>55</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Oxycodone forme orale seche a liberation immediate.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="56">
               <TITLE>
                  <P>Oxycodone forme orale seche a liberation prolongee</P>
               </TITLE>
               <LOT_NO>56</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Oxycodone forme orale seche a liberation prolongee.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="57">
               <TITLE>
                  <P>Paracetamol</P>
               </TITLE>
               <LOT_NO>57</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Paracetamol.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="58">
               <TITLE>
                  <P>Paracetamol</P>
               </TITLE>
               <LOT_NO>58</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Paracetamol.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="59">
               <TITLE>
                  <P>Paracetamol</P>
               </TITLE>
               <LOT_NO>59</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Paracetamol.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="60">
               <TITLE>
                  <P>Paracetamol</P>
               </TITLE>
               <LOT_NO>60</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Paracetamol.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="61">
               <TITLE>
                  <P>Paracetamol injectable</P>
               </TITLE>
               <LOT_NO>61</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Paracetamol injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="62">
               <TITLE>
                  <P>Phenobarbital + cafeine</P>
               </TITLE>
               <LOT_NO>62</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Phenobarbital + cafeine.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="63">
               <TITLE>
                  <P>Primidone</P>
               </TITLE>
               <LOT_NO>63</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Primidone.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="64">
               <TITLE>
                  <P>Tramadol</P>
               </TITLE>
               <LOT_NO>64</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Tramadol.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="65">
               <TITLE>
                  <P>Triptan nasal pour traitement de crise</P>
               </TITLE>
               <LOT_NO>65</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Triptan nasal pour traitement de crise.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="66">
               <TITLE>
                  <P>Triptan oral pour traitement de crise</P>
               </TITLE>
               <LOT_NO>66</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Triptan oral pour traitement de crise.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="67">
               <TITLE>
                  <P>Zuclopenthixol injectable a liberation prolongee</P>
               </TITLE>
               <LOT_NO>67</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRG04"/>
               <SHORT_DESCR>
                  <P>Zuclopenthixol injectable a liberation prolongee.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Intérêts thérapeutique et technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Prestations du fournisseur et performance environnementale</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Coût d'utilisation</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 141-289541</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>20184045</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Adenosine phosphate</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Primiuslab Limited</OFFICIALNAME>
                     <ADDRESS>48 Britannia Street Ground Floor Office Suite Wc1x9bs</ADDRESS>
                     <TOWN>Londres</TOWN>
                     <POSTAL_CODE>01000</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 0808800335</PHONE>
                     <FAX>+33 0808800342</FAX>
                     <n2016:NUTS CODE="UKI"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">8627.45</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>2018404043</CONTRACT_NO>
            <LOT_NO>2</LOT_NO>
            <TITLE>
               <P>Altizide + spironolactone</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Pfizer</OFFICIALNAME>
                     <ADDRESS>23-25 rue du Dr Lannelongue</ADDRESS>
                     <TOWN>Paris</TOWN>
                     <POSTAL_CODE>75668</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 158073121</PHONE>
                     <FAX>+33 158074215</FAX>
                     <n2016:NUTS CODE="FR101"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">490.20</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>20184040</CONTRACT_NO>
            <LOT_NO>3</LOT_NO>
            <TITLE>
               <P>Amiloride + hydrochlorothiazide</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-11</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>MSD France SAS</OFFICIALNAME>
                     <ADDRESS>34 avenue Léonard de Vinci</ADDRESS>
                     <TOWN>Courbevoie</TOWN>
                     <POSTAL_CODE>92400</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 180464000</PHONE>
                     <FAX>+33 180464001</FAX>
                     <n2016:NUTS CODE="FR10"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">72.84</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>20184029</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>Antihemmoroidaire/anesthesique local</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Coopération pharmaceutique français</OFFICIALNAME>
                     <ADDRESS>place Lucien Auvert</ADDRESS>
                     <TOWN>Melun</TOWN>
                     <POSTAL_CODE>77020</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR102"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">2699.38</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="5">
            <CONTRACT_NO>2018404042</CONTRACT_NO>
            <LOT_NO>5</LOT_NO>
            <TITLE>
               <P>Bisoprolol + hydrochlorothiazide</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan SAS</OFFICIALNAME>
                     <ADDRESS>117 allées des Parcs</ADDRESS>
                     <TOWN>Saint-Priest</TOWN>
                     <POSTAL_CODE>69792</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 437257575</PHONE>
                     <FAX>+33 437257576</FAX>
                     <n2016:NUTS CODE="FRK26"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">163.80</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="6">
            <CONTRACT_NO>20184027</CONTRACT_NO>
            <LOT_NO>6</LOT_NO>
            <TITLE>
               <P>Celiprolol</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Arrow Génériques</OFFICIALNAME>
                     <ADDRESS>26 avenue Tony Garnier</ADDRESS>
                     <TOWN>Lyon</TOWN>
                     <POSTAL_CODE>69007</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 472726072</PHONE>
                     <FAX>+33 472726093</FAX>
                     <n2016:NUTS CODE="FRK26"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">551.20</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="7">
            <CONTRACT_NO>20184049</CONTRACT_NO>
            <LOT_NO>7</LOT_NO>
            <TITLE>
               <P>Flavonoides extraits de rutacées</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-19</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Servier</OFFICIALNAME>
                     <ADDRESS>35 rue de Verdun</ADDRESS>
                     <TOWN>Suresnes</TOWN>
                     <POSTAL_CODE>92284</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 155726394</PHONE>
                     <FAX>+33 155727280</FAX>
                     <n2016:NUTS CODE="FR10"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">624</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="8">
            <CONTRACT_NO>2018404042</CONTRACT_NO>
            <LOT_NO>8</LOT_NO>
            <TITLE>
               <P>Acide flusidique 2 % creme</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan SAS</OFFICIALNAME>
                     <ADDRESS>117 allées des Pars</ADDRESS>
                     <TOWN>Saint-Priest</TOWN>
                     <POSTAL_CODE>69792</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 437257575</PHONE>
                     <FAX>+33 437257576</FAX>
                     <n2016:NUTS CODE="FRK26"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">319.20</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="9">
            <CONTRACT_NO>2018404044</CONTRACT_NO>
            <LOT_NO>9</LOT_NO>
            <TITLE>
               <P>Acide fusidique creme 2 %</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Pierre Fabre</OFFICIALNAME>
                     <ADDRESS>parc Industriel de la Chartreuse, BP 222</ADDRESS>
                     <TOWN>Castres</TOWN>
                     <POSTAL_CODE>81106</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRJ27"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">180.60</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="10">
            <CONTRACT_NO>20184027</CONTRACT_NO>
            <LOT_NO>14</LOT_NO>
            <TITLE>
               <P>Émollient pour dermatites atopiques</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Arrow génériques</OFFICIALNAME>
                     <ADDRESS>26 avenue Tony Garnier</ADDRESS>
                     <TOWN>Lyon</TOWN>
                     <POSTAL_CODE>69007</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 472726072</PHONE>
                     <FAX>+33 472726093</FAX>
                     <n2016:NUTS CODE="FRK2"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">672</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="11">
            <CONTRACT_NO>20184034</CONTRACT_NO>
            <LOT_NO>15</LOT_NO>
            <TITLE>
               <P>Eosine aqueuse 2 %</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Gifrer Barbezat</OFFICIALNAME>
                     <ADDRESS>8/10 rue Paule Bert</ADDRESS>
                     <TOWN>Decines</TOWN>
                     <POSTAL_CODE>69153</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 811003040</PHONE>
                     <FAX>+33 472933439</FAX>
                     <n2016:NUTS CODE="FRK2"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">72</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="12">
            <CONTRACT_NO>20184035</CONTRACT_NO>
            <LOT_NO>16</LOT_NO>
            <TITLE>
               <P>Liniment oleocalcaire</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Gilbert</OFFICIALNAME>
                     <ADDRESS>avenue du Général de Gaulles</ADDRESS>
                     <TOWN>Herouville</TOWN>
                     <POSTAL_CODE>14204</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRD11"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">3220</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="13">
            <CONTRACT_NO>20184035</CONTRACT_NO>
            <LOT_NO>17</LOT_NO>
            <TITLE>
               <P>Traitement contre les traumatismes bénins</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Gilbert</OFFICIALNAME>
                     <ADDRESS>avenue du Général de Gaulles</ADDRESS>
                     <TOWN>Herouville</TOWN>
                     <POSTAL_CODE>14204</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 231471507</PHONE>
                     <FAX>+33 231471542</FAX>
                     <n2016:NUTS CODE="FRD11"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">1920</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="14">
            <CONTRACT_NO>20184035</CONTRACT_NO>
            <LOT_NO>18</LOT_NO>
            <TITLE>
               <P>Traitement local cuivre zinc</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Gilbert</OFFICIALNAME>
                     <ADDRESS>avenue du Général de Gaulles</ADDRESS>
                     <TOWN>Herouville</TOWN>
                     <POSTAL_CODE>14204</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <PHONE>+33 231471507</PHONE>
                     <FAX>+33 231471542</FAX>
                     <n2016:NUTS CODE="FRD11"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">3150</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="15">
            <CONTRACT_NO>20184045</CONTRACT_NO>
            <LOT_NO>19</LOT_NO>
            <TITLE>
               <P>Traitement local des dermites irritatives a base D'Au MOINS 20 % D'Oxyde de zinc</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Gilbert</OFFICIALNAME>
                     <ADDRESS>avenue du Général de Gaulles</ADDRESS>
                     <TOWN>Herouville</TOWN>
                     <POSTAL_CODE>14204</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRD11"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">630</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="16">
            <CONTRACT_NO>20184038</CONTRACT_NO>
            <LOT_NO>20</LOT_NO>
            <TITLE>
               <P>Trolamine</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Johnson et Johnson</OFFICIALNAME>
                     <ADDRESS>1 rue Camille Desmoulins</ADDRESS>
                     <TOWN>Issy-les-Moulineaux</TOWN>
                     <POSTAL_CODE>92130</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR105"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">682</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="17">
            <CONTRACT_NO>20184050</CONTRACT_NO>
            <LOT_NO>21</LOT_NO>
            <TITLE>
               <P>Vaseline</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-06</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Terali</OFFICIALNAME>
                     <ADDRESS>23 rue Christophe Plantin</ADDRESS>
                     <TOWN>Fondettes</TOWN>
                     <POSTAL_CODE>37230</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRB04"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">1532.16</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="18">
            <LOT_NO>10</LOT_NO>
            <TITLE>
               <P>Ciclopirox</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="19">
            <LOT_NO>11</LOT_NO>
            <TITLE>
               <P>Dermocorticoide D'Acitivte modere emulsion</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="20">
            <LOT_NO>12</LOT_NO>
            <TITLE>
               <P>Dermocorticoide D'Activite modere lotion</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="21">
            <LOT_NO>13</LOT_NO>
            <TITLE>
               <P>Dermocorticoide d'activite Modéré — Pommade</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="22">
            <LOT_NO>22</LOT_NO>
            <TITLE>
               <P>Artemether + lumefantrine</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="23">
            <LOT_NO>23</LOT_NO>
            <TITLE>
               <P>Benzyle benzoate</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="24">
            <LOT_NO>24</LOT_NO>
            <TITLE>
               <P>Desinfectant antiparasitaire</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="25">
            <LOT_NO>25</LOT_NO>
            <TITLE>
               <P>Diethyl carbamazine</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi Aventis France</OFFICIALNAME>
                     <ADDRESS>8 avenue Raspail</ADDRESS>
                     <TOWN>Gentilly</TOWN>
                     <POSTAL_CODE>94255</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR107"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">134</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="26">
            <LOT_NO>26</LOT_NO>
            <TITLE>
               <P>Permethrine pour usage externe</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="27">
            <CONTRACT_NO>20184028</CONTRACT_NO>
            <LOT_NO>27</LOT_NO>
            <TITLE>
               <P>Pramocaine</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Biocodex</OFFICIALNAME>
                     <ADDRESS>7 avenue Gallieni</ADDRESS>
                     <TOWN>Gentilly</TOWN>
                     <POSTAL_CODE>94257</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR107"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">180.01</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="28">
            <LOT_NO>28</LOT_NO>
            <TITLE>
               <P>Traitement des pediculoses du cuir chevelu malathion</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="29">
            <LOT_NO>29</LOT_NO>
            <TITLE>
               <P>Traitement des pediculoses du cuir chevelu pyrethines</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="30">
            <CONTRACT_NO>20184030</CONTRACT_NO>
            <LOT_NO>30</LOT_NO>
            <TITLE>
               <P>Carbomere</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>CSP</OFFICIALNAME>
                     <ADDRESS>76 avenue du Midi — ZI Sud</ADDRESS>
                     <TOWN>Cournon</TOWN>
                     <POSTAL_CODE>63802</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRK14"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">224</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="31">
            <CONTRACT_NO>20184039</CONTRACT_NO>
            <LOT_NO>31</LOT_NO>
            <TITLE>
               <P>Ether</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Coopération pharmaceutique français</OFFICIALNAME>
                     <ADDRESS>place Lucien Auvert</ADDRESS>
                     <TOWN>Melun</TOWN>
                     <POSTAL_CODE>77020</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR102"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">138</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="32">
            <LOT_NO>32</LOT_NO>
            <TITLE>
               <P>Vert de lissamine</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="33">
            <CONTRACT_NO>20184042</CONTRACT_NO>
            <LOT_NO>33</LOT_NO>
            <TITLE>
               <P>Alpha bloquant dans L'Adenome Prostatique</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>6</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan SAS</OFFICIALNAME>
                     <ADDRESS>117 allée des Parcs</ADDRESS>
                     <TOWN>Saint-Priest</TOWN>
                     <POSTAL_CODE>69792</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRK26"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">4450</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="34">
            <CONTRACT_NO>20184036</CONTRACT_NO>
            <LOT_NO>34</LOT_NO>
            <TITLE>
               <P>Salbutamol</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glaxosmithkline</OFFICIALNAME>
                     <ADDRESS>100 route de Versailles</ADDRESS>
                     <TOWN>Marly-le-Roi</TOWN>
                     <POSTAL_CODE>78163</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR103"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">25.80</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="35">
            <CONTRACT_NO>20184033</CONTRACT_NO>
            <LOT_NO>35</LOT_NO>
            <TITLE>
               <P>Amitriplyne forme orale seche</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-19</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Gerda</OFFICIALNAME>
                     <ADDRESS>6 rue Childebert</ADDRESS>
                     <TOWN>Lyon</TOWN>
                     <POSTAL_CODE>69002</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRK2"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">323.40</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="36">
            <LOT_NO>36</LOT_NO>
            <TITLE>
               <P>Amitriptyline forme injectable</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="37">
            <LOT_NO>37</LOT_NO>
            <TITLE>
               <P>Amitriptyline forme orale liquide</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="38">
            <LOT_NO>38</LOT_NO>
            <TITLE>
               <P>Atomoxetine forme orale</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="39">
            <LOT_NO>39</LOT_NO>
            <TITLE>
               <P>Cafeine citrate</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Coopération pharmaceutique français</OFFICIALNAME>
                     <ADDRESS>place Lucien Auvert</ADDRESS>
                     <TOWN>Melun</TOWN>
                     <POSTAL_CODE>77020</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR102"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">1845</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="40">
            <LOT_NO>40</LOT_NO>
            <TITLE>
               <P>Clotiazepam</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="41">
            <LOT_NO>41</LOT_NO>
            <TITLE>
               <P>Dexamphetamine forme orale</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="42">
            <LOT_NO>42</LOT_NO>
            <TITLE>
               <P>Doxepine</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="43">
            <CONTRACT_NO>20184037</CONTRACT_NO>
            <LOT_NO>43</LOT_NO>
            <TITLE>
               <P>Fentanyl</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Grunenthal SAS</OFFICIALNAME>
                     <ADDRESS>Immeuble Eureka</ADDRESS>
                     <TOWN>Nanterre</TOWN>
                     <POSTAL_CODE>92024</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR105"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">270</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="44">
            <CONTRACT_NO>20184041</CONTRACT_NO>
            <LOT_NO>44</LOT_NO>
            <TITLE>
               <P>Hydromorphone forme orale a liberation prolongee</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mundipharma SAS</OFFICIALNAME>
                     <ADDRESS>tour Cristal</ADDRESS>
                     <TOWN>Paris</TOWN>
                     <POSTAL_CODE>75015</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR101"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">202.92</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="45">
            <LOT_NO>45</LOT_NO>
            <TITLE>
               <P>Hydroxyzine injectable</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="46">
            <CONTRACT_NO>20184046</CONTRACT_NO>
            <LOT_NO>46</LOT_NO>
            <TITLE>
               <P>Levodopa + benserazide</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Roche</OFFICIALNAME>
                     <ADDRESS>30 cours de l'Île Seguin</ADDRESS>
                     <TOWN>Boulogne Billancourt</TOWN>
                     <POSTAL_CODE>92650</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR105"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">1313</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="47">
            <LOT_NO>47</LOT_NO>
            <TITLE>
               <P>Lidocaine noradrenaline</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="48">
            <CONTRACT_NO>20184047</CONTRACT_NO>
            <LOT_NO>48</LOT_NO>
            <TITLE>
               <P>Loprazolam</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi Aventis France</OFFICIALNAME>
                     <ADDRESS>82 avenue Raspail</ADDRESS>
                     <TOWN>Gentilly</TOWN>
                     <POSTAL_CODE>94255</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR107"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">220</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="49">
            <LOT_NO>49</LOT_NO>
            <TITLE>
               <P>Morphine chlorhydrate</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="50">
            <CONTRACT_NO>20184031</CONTRACT_NO>
            <LOT_NO>50</LOT_NO>
            <TITLE>
               <P>Morphine sulfate forme lp</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-11</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Etypharm</OFFICIALNAME>
                     <ADDRESS>179 bureaux de la Colline</ADDRESS>
                     <TOWN>Saint-Cloud</TOWN>
                     <POSTAL_CODE>92210</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR105"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">3533</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="51">
            <CONTRACT_NO>20184031</CONTRACT_NO>
            <LOT_NO>51</LOT_NO>
            <TITLE>
               <P>Morphine sulfate liberation immediate</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-11</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Ethypharm</OFFICIALNAME>
                     <ADDRESS>179 bureaux de la Colline</ADDRESS>
                     <TOWN>Saint-Cloud</TOWN>
                     <POSTAL_CODE>92210</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR105"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">1424</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="52">
            <LOT_NO>52</LOT_NO>
            <TITLE>
               <P>Nordazepam</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="53">
            <LOT_NO>53</LOT_NO>
            <TITLE>
               <P>Oxycodone</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="54">
            <CONTRACT_NO>20184041</CONTRACT_NO>
            <LOT_NO>54</LOT_NO>
            <TITLE>
               <P>Oxycodone forme orale liquide</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-17</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mundipharma SAS</OFFICIALNAME>
                     <ADDRESS>tour Cristal 7-11 quai André Citroen</ADDRESS>
                     <TOWN>Paris</TOWN>
                     <POSTAL_CODE>75015</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR101"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">60</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="55">
            <CONTRACT_NO>20184027</CONTRACT_NO>
            <LOT_NO>55</LOT_NO>
            <TITLE>
               <P>Oxycodone forme orale seche a liberation immediate</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Arrow Génériques</OFFICIALNAME>
                     <ADDRESS>26 avenue Tony Garnier</ADDRESS>
                     <TOWN>Lyon</TOWN>
                     <POSTAL_CODE>69007</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRK2"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">1797.50</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="56">
            <CONTRACT_NO>20184042</CONTRACT_NO>
            <LOT_NO>56</LOT_NO>
            <TITLE>
               <P>Oxycodone forme orale sèche à libération prolongée</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mylan SAS</OFFICIALNAME>
                     <ADDRESS>117 allée des Parcs</ADDRESS>
                     <TOWN>Saint-Priest</TOWN>
                     <POSTAL_CODE>69792</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRK26"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">6060</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="57">
            <CONTRACT_NO>20184047</CONTRACT_NO>
            <LOT_NO>57</LOT_NO>
            <TITLE>
               <P>Paracetamol suspension buvable sans sucre</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi Aventis</OFFICIALNAME>
                     <ADDRESS>82 avenue Raspail</ADDRESS>
                     <TOWN>Gentilly</TOWN>
                     <POSTAL_CODE>94255</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR107"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">1380</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="58">
            <CONTRACT_NO>20184051</CONTRACT_NO>
            <LOT_NO>58</LOT_NO>
            <TITLE>
               <P>Paracetamol</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-14</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>UPSA SAS</OFFICIALNAME>
                     <ADDRESS>3 rue Joseph Monier</ADDRESS>
                     <TOWN>Rueil Malmaison</TOWN>
                     <POSTAL_CODE>92506</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR105"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">24</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="59">
            <CONTRACT_NO>20184047</CONTRACT_NO>
            <LOT_NO>59</LOT_NO>
            <TITLE>
               <P>Paracetamol</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Sanofi Aventis</OFFICIALNAME>
                     <ADDRESS>82 avenue Raspail</ADDRESS>
                     <TOWN>Gentilly</TOWN>
                     <POSTAL_CODE>94255</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR107"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">95</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="60">
            <LOT_NO>60</LOT_NO>
            <TITLE>
               <P>Paracetamol — 100 mg suppositoire</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="61">
            <CONTRACT_NO>20184039</CONTRACT_NO>
            <LOT_NO>61</LOT_NO>
            <TITLE>
               <P>Paracetamol injectable</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-19</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Maco Pharma SAS</OFFICIALNAME>
                     <ADDRESS>rue Lorthiois</ADDRESS>
                     <TOWN>Mouvaux</TOWN>
                     <POSTAL_CODE>59240</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRE11"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">106550</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="62">
            <CONTRACT_NO>20184032</CONTRACT_NO>
            <LOT_NO>62</LOT_NO>
            <TITLE>
               <P>Phenobarbital + cafeine</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Genevrier</OFFICIALNAME>
                     <ADDRESS>280 rue de Goa</ADDRESS>
                     <TOWN>Sophia Antipolis</TOWN>
                     <POSTAL_CODE>06901</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRL03"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">37.90</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="63">
            <CONTRACT_NO>20184048</CONTRACT_NO>
            <LOT_NO>63</LOT_NO>
            <TITLE>
               <P>Primidone</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>SERB SAS</OFFICIALNAME>
                     <ADDRESS>40 avenue Georges V</ADDRESS>
                     <TOWN>Paris</TOWN>
                     <POSTAL_CODE>75008</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR101"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">66</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="64">
            <CONTRACT_NO>20184037</CONTRACT_NO>
            <LOT_NO>64</LOT_NO>
            <TITLE>
               <P>Tramadol</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-07</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Gruenenthal SAS</OFFICIALNAME>
                     <ADDRESS>19 rue Ernest Renan, CS 90001</ADDRESS>
                     <TOWN>Nanterre</TOWN>
                     <POSTAL_CODE>92024</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR105"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">257.40</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="65">
            <CONTRACT_NO>20184036</CONTRACT_NO>
            <LOT_NO>65</LOT_NO>
            <TITLE>
               <P>Triptan nasal pour traitement de crise</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Glaxosmithkline</OFFICIALNAME>
                     <ADDRESS>100 route de Versailles</ADDRESS>
                     <TOWN>Marly-le-Roi</TOWN>
                     <POSTAL_CODE>78163</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FR103"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">700</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="66">
            <CONTRACT_NO>20184027</CONTRACT_NO>
            <LOT_NO>66</LOT_NO>
            <TITLE>
               <P>Triptan oral pour traitement de crise</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2017-12-08</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Arrow Génériques</OFFICIALNAME>
                     <ADDRESS>26 avenue Tony Garnier</ADDRESS>
                     <TOWN>Lyon</TOWN>
                     <POSTAL_CODE>69007</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRK2"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">65</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="67">
            <LOT_NO>67</LOT_NO>
            <TITLE>
               <P>Zuclopenthixol injectable a liberation prolongee</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Tribunal administratif de Nantes</OFFICIALNAME>
               <ADDRESS>6 allée Île Gloriette</ADDRESS>
               <TOWN>Nantes</TOWN>
               <POSTAL_CODE>44000</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 240994600</PHONE>
               <FAX>+33 240994658</FAX>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_MEDIATION_BODY>
               <OFFICIALNAME>Comité consultatif interrégional de règlement amiable des litiges relatifs aux marchés publics</OFFICIALNAME>
               <ADDRESS>8 rue de Châteaubriant</ADDRESS>
               <TOWN>Nantes</TOWN>
               <POSTAL_CODE>44000</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
            </ADDRESS_MEDIATION_BODY>
            <REVIEW_PROCEDURE>
               <P>Référé pré-contractuel depuis le début de la procédure jusqu'à la signature du contrat: devant le tribunal administratif de Nantes (article L.551-1 du Code de justice administrative).</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-01-11</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
